Activity of exemestane, an irreversible, oral, aromatase inhibitor in metastatic postrnenopausal breast cancer patients (MBC) failing tamoxifen (TAM)
- 30 September 1998
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 34, S91-91
- https://doi.org/10.1016/s0959-8049(98)80370-5